![](/media/vdqhqzem/salmon.png)
Uppsala Reports editor
@UMCGlobalSafety
In this festive edition of Drug Safety Matters, we wrap up the year that was and look ahead to the year that will be – with a little help from one of our friends.
WHAT DID THE DRUG SAFETY COMMUNITY ACHIEVE IN 2023 and how will the field develop in 2024? As the year comes to a close, we asked Angela Caro, president of the International Society of Pharmacovigilance, to walk us through current and future trends in pharmacovigilance.
Among her predictions, hear her thoughts on patient engagement – a hot topic that is going to get hotter – as well as the challenges she foresees closest to home in Latin America.
Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:
Effective risk communication is a mainstay of successful pharmacovigilance, yet examples of poor risk mitigation abound. Where are we failing, and what can be done about it?
Perspective / 20 November 2023
Are you and your patient talking about the same thing when you discuss risk? Most likely not, and understanding this is key to effective risk communication.
Perspective / 18 March 2024
As we prepare for the eighth rendition of the #MedSafetyWeek campaign, we talk to some seasoned campaigners on how to run a successful campaign.
Perspective / 30 October 2023